{
 "awd_id": "2102840",
 "agcy_id": "NSF",
 "tran_type": "Grant",
 "awd_istr_txt": "Fellowship Award",
 "awd_titl_txt": "PostDoctoral Research Fellowship",
 "cfda_num": "47.049",
 "org_code": "03040000",
 "po_phone": "7032924878",
 "po_email": "adpollin@nsf.gov",
 "po_sign_block_name": "Andrew Pollington",
 "awd_eff_date": "2021-09-01",
 "awd_exp_date": "2025-08-31",
 "tot_intn_awd_amt": 150000.0,
 "awd_amount": 150000.0,
 "awd_min_amd_letter_date": "2021-03-29",
 "awd_max_amd_letter_date": "2021-03-29",
 "awd_abstract_narration": "This award is made as part of the FY 2021 Mathematical Sciences Postdoctoral Research Fellowships Program. Each of the fellowships supports a research and training project at a host institution in the mathematical sciences, including applications to other disciplines, under the mentorship of a sponsoring scientist. \r\n\r\nThe title of the project for this fellowship to Nima Hejazi is \"Nonparametric Causal Inference in Complex Randomized and Observational Studies.\" The host institution for the fellowship is Weill Cornell School of Medical Sciences, and the sponsoring scientist is Ivan Diaz.\r\n\r\nThis award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.",
 "awd_arra_amount": 0.0,
 "dir_abbr": "MPS",
 "org_dir_long_name": "Directorate for Mathematical and Physical Sciences",
 "div_abbr": "DMS",
 "org_div_long_name": "Division Of Mathematical Sciences",
 "awd_agcy_code": "4900",
 "fund_agcy_code": "4900",
 "pi": [
  {
   "pi_role": "Principal Investigator",
   "pi_first_name": "Nima",
   "pi_last_name": "Hejazi",
   "pi_mid_init": "S",
   "pi_sufx_name": "",
   "pi_full_name": "Nima S Hejazi",
   "pi_email_addr": "",
   "nsf_id": "000836163",
   "pi_start_date": "2021-03-29",
   "pi_end_date": null
  }
 ],
 "inst": {
  "inst_name": "Hejazi, Nima S",
  "inst_street_address": "",
  "inst_street_address_2": "",
  "inst_city_name": "Oakland",
  "inst_state_code": "CA",
  "inst_state_name": "California",
  "inst_phone_num": "",
  "inst_zip_code": "94611",
  "inst_country_name": "United States",
  "cong_dist_code": "09",
  "st_cong_dist_code": "CA09",
  "org_lgl_bus_name": "",
  "org_prnt_uei_num": "",
  "org_uei_num": ""
 },
 "perf_inst": {
  "perf_inst_name": "Weill Cornell Graduate School of Medical Sciences",
  "perf_str_addr": null,
  "perf_city_name": "New York",
  "perf_st_code": "NY",
  "perf_st_name": "New York",
  "perf_zip_code": "100654805",
  "perf_ctry_code": "US",
  "perf_cong_dist": "12",
  "perf_st_cong_dist": "NY12",
  "perf_ctry_name": "United States",
  "perf_ctry_flag": "1"
 },
 "pgm_ele": [
  {
   "pgm_ele_code": "060Y00",
   "pgm_ele_name": "Workforce (MSPRF) MathSciPDFel"
  }
 ],
 "pgm_ref": [
  {
   "pgm_ref_code": "102Z",
   "pgm_ref_txt": "COVID-Disproportionate Impcts Inst-Indiv"
  },
  {
   "pgm_ref_code": "9219",
   "pgm_ref_txt": "POSTDOCTORAL FELLOWSHIPS IN MATH SCIENCE"
  }
 ],
 "app_fund": [
  {
   "app_code": "0121",
   "app_name": "NSF RESEARCH & RELATED ACTIVIT",
   "app_symb_id": "040100",
   "fund_code": "01002122DB",
   "fund_name": "NSF RESEARCH & RELATED ACTIVIT",
   "fund_symb_id": "040100"
  }
 ],
 "oblg_fy": [
  {
   "fund_oblg_fiscal_yr": 2021,
   "fund_oblg_amt": 150000.0
  }
 ],
 "por": {
  "por_cntn": "<div class=\"porColContainerWBG\">\n<div class=\"porContentCol\"><p>As studies in medicine and public health collect ever greater amounts of data, both on individual patients and on patient populations, the types of scientific questions that may be asked grows more diverse. Yet, the increasing complexity of these studies and the data that they generate has made answering questions of mechanism challenging. The maturing science of causal inference, which draws on foundations in statistics and computer science, is well-prepared to address only a subset of today&rsquo;s scientific inquiries, most commonly those concerning the total effect on an outcome attributable to a particular treatment course. Modern studies are often observational (randomization can be impractical or unethical), reliant upon biased sampling designs (to curb costs), and plagued by confounding (for lack of randomization or owing to interest in post-randomization events). Developing rigorous answers to important scientific questions requires carefully tailoring statistical and causal inference methodology to these complications. The new techniques result form this must also be capable of incorporating the state-of-the-art in machine learning to ensure the robustness and reliability of the statistical answers they provide.</p>\n<p>This postdoctoral fellowship sought to develop statistical techniques to address two important and broad complications arising commonly in today&rsquo;s biomedical and public health studies: (1) correcting for outcome-dependent, two-phase sampling (e.g., case-cohort) designs, which lead to biased samples; and (2) formulating novel estimands and efficient estimators for mechanistic, path-specific effects. Both sets of aims, written in 2020 and carried out in 2021-2022, were motivated by urgent and quickly evolving questions posed as part of the immune correlates analysis of U.S. Government-funded vaccines to curb the COVID-19 pandemic. Via close collaboration with the immune correlates analysis team of the COVID-19 Prevention Network, of which the fellow served as a core member, these pursuits were tied to scientific questions like &ldquo;to what extent is the protective effect conferred by an mRNA COVID-19 vaccine, in terms of reducing risk of infection or symptomatic disease, biologically mediated by targeted immunologic biomarkers?&rdquo;. As these trials commonly measured biomarkers in a randomly selected subset of participants, as well as all those who acquired COVID-19 over the study period, only a non-representative (biased) subsample of biomarker measurements was available to answer such questions, and corrective techniques were necessary to ensure that the statistical answers were reflective of the vaccine efficacy clinical trial&rsquo;s target population. The work performed developed both novel techniques for this purpose and produced several open source software packages (in the R language) that implemented these robust techniques for widespread use.</p><br>\n<p>\n\t\t\t\t      \tLast Modified: 07/20/2022<br>\n\t\t\t\t\tModified by: Nima&nbsp;S&nbsp;Hejazi</p>\n</div>\n<div class=\"porSideCol\"></div>\n</div>",
  "por_txt_cntn": "\nAs studies in medicine and public health collect ever greater amounts of data, both on individual patients and on patient populations, the types of scientific questions that may be asked grows more diverse. Yet, the increasing complexity of these studies and the data that they generate has made answering questions of mechanism challenging. The maturing science of causal inference, which draws on foundations in statistics and computer science, is well-prepared to address only a subset of today\u2019s scientific inquiries, most commonly those concerning the total effect on an outcome attributable to a particular treatment course. Modern studies are often observational (randomization can be impractical or unethical), reliant upon biased sampling designs (to curb costs), and plagued by confounding (for lack of randomization or owing to interest in post-randomization events). Developing rigorous answers to important scientific questions requires carefully tailoring statistical and causal inference methodology to these complications. The new techniques result form this must also be capable of incorporating the state-of-the-art in machine learning to ensure the robustness and reliability of the statistical answers they provide.\n\nThis postdoctoral fellowship sought to develop statistical techniques to address two important and broad complications arising commonly in today\u2019s biomedical and public health studies: (1) correcting for outcome-dependent, two-phase sampling (e.g., case-cohort) designs, which lead to biased samples; and (2) formulating novel estimands and efficient estimators for mechanistic, path-specific effects. Both sets of aims, written in 2020 and carried out in 2021-2022, were motivated by urgent and quickly evolving questions posed as part of the immune correlates analysis of U.S. Government-funded vaccines to curb the COVID-19 pandemic. Via close collaboration with the immune correlates analysis team of the COVID-19 Prevention Network, of which the fellow served as a core member, these pursuits were tied to scientific questions like \"to what extent is the protective effect conferred by an mRNA COVID-19 vaccine, in terms of reducing risk of infection or symptomatic disease, biologically mediated by targeted immunologic biomarkers?\". As these trials commonly measured biomarkers in a randomly selected subset of participants, as well as all those who acquired COVID-19 over the study period, only a non-representative (biased) subsample of biomarker measurements was available to answer such questions, and corrective techniques were necessary to ensure that the statistical answers were reflective of the vaccine efficacy clinical trial\u2019s target population. The work performed developed both novel techniques for this purpose and produced several open source software packages (in the R language) that implemented these robust techniques for widespread use.\n\n\t\t\t\t\tLast Modified: 07/20/2022\n\n\t\t\t\t\tSubmitted by: Nima S Hejazi"
 }
}